المؤلفون: G Palmieri, F Consoli, M Valente, Corrado Caracò, Paolo Antonio Ascierto, Michele Maio, M Guida, G Rinaldi, Angelo Paolo Dei Tos, R Berardi, Giovanni Grignani, Paola Queirolo, Francesca Spada, Nicola Fazio, A Córdova, L Repetto, B Vincenzi, D Massi, G Fabbrocini, A Berruti, L Tagliaferri, P Rubegni, P Poletti, M Barberis, F Picciotto, Paolo Bossi, M Gatti, Vanna Chiarion Sileni, Pietro Quaglino, GC Antonini Cappellini, L Antonuzzo, G Badalamenti, F Bassetto, A Bongiovanni, P Bonomo, L Borgognoni, V Borzillo, F Bruder, D Campana, R Depenni, AM Di Giacomo, MC Fargnoli, V Ferraresi, F Ferrau, MT Fierro, F Gelsomino, D Giuffrida, P Graziano, C Gregorelli, R Mazzarotto, L Milesi, AM Minisini, F Morgese, P Muto, R Patuzzo, G Pellacani, J Pigozzo, N Pimpinelli, G Rubino, F Spagnolo, E Tanda, MC Tronconi, M Tucci, I Zalaudek

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/10/6/e004742.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/803650a72e7f4b7aa71f13ef3550f03b

المؤلفون: Santoro A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Masini S; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Cavina R; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Tronconi MC; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., De Vincenzo F; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy.

المصدر: Frontiers in oncology [Front Oncol] 2023 Jul 31; Vol. 13, pp. 1205720. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Daprà V; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Airoldi M; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Bartolini M; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Fazio R; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Mondello G; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Prete MG; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., D'Agostino G; Radiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Foppa C; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Spinelli A; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Puccini A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy., Santoro A; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 29; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy* , Rectal Neoplasms*/pathology, Humans ; Chemoradiotherapy ; Rectum/pathology ; Chemotherapy, Adjuvant ; Neoplasm Staging

المؤلفون: Rubatto M; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy. Electronic address: rubattomarco@gmail.it., Fava P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy., Stanganelli I; Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy., Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy., Pigozzo J; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Ridolfi L; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy., Trojaniello C; Department of Melanoma and Cancer Immunotherapy, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Bersanelli M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Garutti M; CRO Aviano National Cancer Institute IRCCS, 33081 Aviano, Italy., Indini A; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., De Risi I; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., De Tursi M; Department of Medical, Oral and Biotechnological Sciences, Gabriele d'Annunzio University of Chieti and Pescara, Chieti, Italy., Merelli B; Unit of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Piazza OMS 1, 24100 Bergamo, Italy., Morgese F; Clinica Oncologica, Università Politecnica delle Marche, AOU Ospedali Riuniti Di Ancona, Ancona, Italy., Occelli M; Department of Medicine, Clinical Oncology and Translational Research, Azienda Ospedaliera Santa Croce and Carle University Teaching Hospital, Cuneo, Italy., Cappellini GCA; UOC Oncologia Interpresidio, Ospedale Sandro Pertini, ASL Roma 2, Roma, Italy., Poletto S; Istituto di Candiolo, FPO - IRCCS, Candiolo, Italy; Department of Oncology, University of Turin, Torino, Italy., Fedele D; Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, Italy., Brugnara S; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Frisinghelli M; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Formisano L; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy., Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero, Vulture, Italy., Tucci M; Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', Section of Internal Medicine and Oncology, P.za Giulio Cesare, 11, 70124 Bari, Italy., Russillo M; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy., Ceroni L; University of Turin, Turin, Italy., Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy., Targato G; Department of Medical Oncology, Academic Hospital of Udine, Italy., Strippoli S; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jul; Vol. 187, pp. 25-35. Date of Electronic Publication: 2023 Mar 23.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local* , Melanoma*/pathology, Humans ; Aged ; Retrospective Studies ; Disease Progression ; Progression-Free Survival ; Syndrome

المؤلفون: Toso F; Dermatology Unit, Humanitas Research Hospital-IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Tronconi MC; Oncology Unit, Cancer Center, Humanitas Research Hospital-IRCCS, Rozzano, Italy., Cortese A; Dermatology Unit, Humanitas Research Hospital-IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Fiorillo G; Dermatology Unit, Humanitas Research Hospital-IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Bressan A; Pathology Unit, Humanitas Research Hospital-IRCCS, Rozzano, Italy., Costanzo A; Dermatology Unit, Humanitas Research Hospital-IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Borroni RG; Dermatology Unit, Humanitas Research Hospital-IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

المصدر: Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15800. Date of Electronic Publication: 2022 Sep 14.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-8019 (Electronic) Linking ISSN: 13960296 NLM ISO Abbreviation: Dermatol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell*/drug therapy , Carcinoma, Squamous Cell*/pathology , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology , Antineoplastic Agents*/therapeutic use, Humans ; Imiquimod/therapeutic use ; Aminoquinolines/therapeutic use ; Eyelids/pathology ; Administration, Topical ; Treatment Outcome

المؤلفون: Tronconi MC; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Marinello A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Solferino A; Pharmacist Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Grimaudo S; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Ciccarelli M; Respiratory Medicine Unit, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Manara S; Department of Pathology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Cozzaglio L; Sarcoma, Melanoma and Rare Tumors Surgery Unit, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Mancini L; Dermatology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Borroni R; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Dermatology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Santoro A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

المصدر: Case reports in oncology [Case Rep Oncol] 2022 May 30; Vol. 15 (2), pp. 560-565. Date of Electronic Publication: 2022 May 30 (Print Publication: 2022).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE

المؤلفون: Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy., Solferino A; Pharmacist Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy., Giordano L; Biostatistics Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy., Borroni R; Dermatology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Mancini L; Dermatology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy., Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

المصدر: Frontiers in oncology [Front Oncol] 2020 Nov 13; Vol. 10, pp. 563404. Date of Electronic Publication: 2020 Nov 13 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Mannavola F; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy., Mandala M; Medical Oncology Unit, Department of Oncology and Hematology, Azienda Ospedaliera Papa Giovanni XXIII Hospital, Bergamo, Italy., Todisco A; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy., Sileni VC; Melanoma Oncology Unit, Veneto Institute of Oncology, Scientific Institute for Research, Hospitalization and Healthcare, Padua, Italy., Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Minisini AM; Department of Oncology, Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy., Pala L; Division of Melanoma, Sarcoma and Rare Tumors, European Institute of Oncology, Scientific Institute for Research, Hospitalization and Healthcare, Milan, Italy., Morgese F; Oncology Clinic, Università Politecnica delle Marche, Ancona, Italy., Di Guardo L; Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology, National Institute of Tumori, Milan, Italy., Stucci LS; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy., Guida M; IRCCS Giovanni Paolo II, Cancer Institute, Bari, Italy., Indini A; Medical Oncology Unit, Department of Oncology and Hematology, Azienda Ospedaliera Papa Giovanni XXIII Hospital, Bergamo, Italy., Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Ferraresi V; First Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Marconcini R; Medical Oncology Department, Santa Chiara Hospital, University of Pisa, Pisa, Italy., Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy., Rossi E; Medical Oncology, Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS, Rome, Italy., Nigro O; Medical Oncology, ASST-Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Occelli M; Medical Oncology Unit, Santa Croce and Carle Teaching Hospital, Cuneo, Italy., Cortellini A; Department of Biotechnological and Applied Clinical Sciences, San Salvatore Hospital, University of L'Aquila, L'Aquila, Italy., Quadrini S; Medical Oncology Unit, Azienda Sanitaria Locale Frosinone, Frosinone, Italy., Palmieri G; Unit of Cancer Genetics, Institute of Genetic and Biomedical Research, National Research Council, Sassari, Italy., Pigozzo J; Melanoma Oncology Unit, Veneto Institute of Oncology, Scientific Institute for Research, Hospitalization and Healthcare, Padua, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Vitale MG; Department of Oncology, Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy., Strippoli S; IRCCS Giovanni Paolo II, Cancer Institute, Bari, Italy., Ferrucci PF; Division of Melanoma, Sarcoma and Rare Tumors, European Institute of Oncology, Scientific Institute for Research, Hospitalization and Healthcare, Milan, Italy., Berardi R; Oncology Clinic, Università Politecnica delle Marche, Ancona, Italy., Randon G; Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology, National Institute of Tumori, Milan, Italy., Cardone P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Schinzari G; Medical Oncology, Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS, Rome, Italy., Silvestris F; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy., Tucci M; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.; IRCCS Giovanni Paolo II, Cancer Institute, Bari, Italy.

المصدر: Frontiers in oncology [Front Oncol] 2020 Sep 15; Vol. 10, pp. 1652. Date of Electronic Publication: 2020 Sep 15 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Bozzarelli S; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Rimassa L; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20090, Italy., Giordano L; Biostatistics Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Sala S; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Tronconi MC; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Pressiani T; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Smiroldo V; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Prete MG; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Spaggiari P; Anatomic Pathology Unit, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy., Personeni N; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20090, Italy., Santoro A; Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20090, Italy.

المصدر: Future oncology (London, England) [Future Oncol] 2019 Dec; Vol. 15 (35), pp. 4009-4017. Date of Electronic Publication: 2019 Nov 20.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Pancreatic Neoplasms/*drug therapy , Pancreatic Neoplasms/*pathology , Phenylurea Compounds/*therapeutic use , Pyridines/*therapeutic use, Aged ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Drug Resistance, Neoplasm ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Neovascularization, Pathologic/drug therapy ; Pancreatic Neoplasms/mortality ; Phenylurea Compounds/administration & dosage ; Phenylurea Compounds/adverse effects ; Prognosis ; Pyridines/administration & dosage ; Pyridines/adverse effects ; Retreatment ; Treatment Outcome

المؤلفون: Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy. Electronic address: lorenza.rimassa@cancercenter.humanitas.it., Bozzarelli S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy., Cordio S; Medical Oncology Unit, Ospedale Garibaldi, Catania, Italy., Lonardi S; Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova, Italy., Toppo L; Medical Oncology Unit, Istituti Ospitalieri, Cremona, Italy., Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy., Bordonaro R; Medical Oncology Unit, Ospedale Garibaldi, Catania, Italy., Di Bartolomeo M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tomasello G; Medical Oncology Unit, Istituti Ospitalieri, Cremona, Italy., Dadduzio V; Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova, Italy., Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy., Piombo C; Pathology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy., Giordano L; Biostatistics Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy., Gloghini A; Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Tommaso L; Pathology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2019 Jun; Vol. 18 (2), pp. 125-132.e2. Date of Electronic Publication: 2019 Feb 14.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Cetuximab/*therapeutic use , Colorectal Neoplasms/*drug therapy , Pyrrolidinones/*therapeutic use , Quinolines/*therapeutic use, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Cetuximab/pharmacology ; Chemotherapy-Induced Febrile Neutropenia/epidemiology ; Chemotherapy-Induced Febrile Neutropenia/etiology ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Drug Eruptions/epidemiology ; Drug Eruptions/etiology ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/antagonists & inhibitors ; Fatigue/chemically induced ; Fatigue/epidemiology ; Female ; Follow-Up Studies ; Gene Amplification ; Gene Expression Regulation, Neoplastic ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Panitumumab/pharmacology ; Panitumumab/therapeutic use ; Progression-Free Survival ; Proto-Oncogene Proteins c-met/genetics ; Proto-Oncogene Proteins c-met/metabolism ; Proto-Oncogene Proteins p21(ras)/genetics ; Pyrrolidinones/pharmacology ; Quinolines/pharmacology